Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology ...
Rogers Sugar Inc. ("our," "we", "us" or "Rogers") today reported fourth quarter of fiscal 2025 results with consolidated adjusted EBITDA of $39.5 million and $150.4 million for the current quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback